Haesen, S.; Jager, M.M.; Brillouet, A.; de Laat, I.; Vastmans, L.; Verghote, E.; Delaet, A.; D’Haese, S.; Hamad, I.; Kleinewietfeld, M.;
et al. Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity. Antioxidants 2024, 13, 112.
https://doi.org/10.3390/antiox13010112
AMA Style
Haesen S, Jager MM, Brillouet A, de Laat I, Vastmans L, Verghote E, Delaet A, D’Haese S, Hamad I, Kleinewietfeld M,
et al. Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity. Antioxidants. 2024; 13(1):112.
https://doi.org/10.3390/antiox13010112
Chicago/Turabian Style
Haesen, Sibren, Manon Marie Jager, Aline Brillouet, Iris de Laat, Lotte Vastmans, Eline Verghote, Anouk Delaet, Sarah D’Haese, Ibrahim Hamad, Markus Kleinewietfeld,
and et al. 2024. "Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity" Antioxidants 13, no. 1: 112.
https://doi.org/10.3390/antiox13010112
APA Style
Haesen, S., Jager, M. M., Brillouet, A., de Laat, I., Vastmans, L., Verghote, E., Delaet, A., D’Haese, S., Hamad, I., Kleinewietfeld, M., Mebis, J., Mullens, W., Lambrichts, I., Wolfs, E., Deluyker, D., & Bito, V.
(2024). Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity. Antioxidants, 13(1), 112.
https://doi.org/10.3390/antiox13010112
